Surveillance of Epstein-Barr virus infection as a risk factor for post-transplant lymphoproliferative disorder in pediatric renal transplant recipients.
- 12 February 2004
- journal article
- editorial
- Published by Springer Nature in Pediatric Nephrology
- Vol. 19 (4) , 365-8
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The post-transplant lymphoproliferative disorder?a literature reviewPediatric Nephrology, 2004
- Adenotonsillar hypertrophy and post-transplant lymphoproliferative disorder in pediatric renal transplant recipientsPediatric Nephrology, 2004
- Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease1Transplantation, 2002
- REDUCTION IN IMMUNOSUPPRESSION AS INITIAL THERAPY FOR POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER: ANALYSIS OF PROGNOSTIC VARIABLES AND LONG-TERM FOLLOW-UP OF 42 ADULT PATIENTS1Transplantation, 2001
- Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response.2000
- EPSTEIN-BARR VIRUS-INDUCED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERSTransplantation, 1999
- Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop.1997
- A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.1994
- Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease.1994
- The diagnosis and treatment of posttransplant lymphoproliferative disordersCurrent Problems in Surgery, 1988